Professional of the Year - Cancer Drug Research
|
Tricia J. VosMillennium: The Takeda Oncology Company40 Landsdowne St. Cambridge MA 02139 |
| Industry: | Pharmaceutical |
| Born: | July 5, 1972 |
| Current Organization: | Millennium: The Takeda Oncology Company |
| Type of Organization: | R&D |
| Major Product: | Cancer drugs |
| Area of Distribution: | National/International |
| Expertise: | Oncology, Drug Discovery, Medicinal Chemistry |
| University/Degree: | B.A., Franklin & Marshall College; Ph.D., University of Minnesota |
| Title: | Senior Scientist II |
| Honors & Awards: | Phi Beta Kappa |
| Published Works: | Publications include-"Antitumor Activity of MLN8054, an Orally Small-Molecule Inhibitor of Aurora A Kinase", Manfredi MC, Ecsedy JA, Meetze KA, Balani SK, Burenkova O, Chen W, Galvin KM, Hoar KM, Huck JJ, LeRoy RJ, Ray ET, Sells TB, Stringer B, Stroud SG, Vos TJ, Weatherhead GS, Wysong DR, Zhang M, Bolen JD, Claiborne CF, Proc. Natl. Acad. Sci. (USA) 2007, 104(10), 4106-4111 and "Identification and Structure-Activity Relationships of a New Series of Melanocortin-4 Receptor Antagonists", Vos TJ, Balani S, Blackburn C, Chau R, Danca MD, Drabic SV, Farrer CA, Patane MA, Stroud SG, Yowe, DL, Claiborne CF, Bioorg. Med. Chem. Lett. 2006, 16, 2302-2305; Patents and Patent Applications include- "Preparation of Pyrazoline Derivatives with Raf Kinase Inhibitory Activity", Adams RS, Duffey M, Gould AE, Greenspan PD, Kulkarni BA, Vos TJ, WO 08/079277; Presentations include- "Small Molecule MC4 Receptor Antagonists", Vos TJ, IBC's Hit to Lead Success Stories Conference, San Diego, CA, 2005 |
| Affiliations: | ACS |
| Email: | tricia.vos@mpi.com |
| Website: | http://www.mlmn.com |